株探米国株
日本語 英語
エドガーで原本を確認する
00007465982025Q3false00007465982025-05-162025-05-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 16, 2025
BRADY CORPORATION
(Exact name of registrant as specified in its charter)
Commission File Number 1-14959
Wisconsin   39-0178960
(State or other jurisdiction of incorporation or organization)   (IRS Employer Identification No.)
6555 West Good Hope Road
Milwaukee, Wisconsin 53223
(Address of principal executive offices and Zip Code)
(414) 358-6600
(Registrant’s Telephone Number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per share BRC New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐


Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On May 16, 2025, Brady Corporation (the “Company”) issued a press release announcing its fiscal 2025 third quarter financial results. A copy of the press release is being furnished to the Securities and Exchange Commission as Exhibit 99.1 attached hereto and is incorporated herein by reference.

Item 7.01 REGULATION FD DISCLOSURE

On May 16, 2025, the Company hosted a conference call related to its fiscal 2025 third quarter financial results. A copy of the slides referenced in the conference call, which is also posted on the Company’s website, is being furnished to the Securities and Exchange Commission as Exhibit 99.2 attached hereto and is incorporated herein by reference.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits
EXHIBIT NUMBER DESCRIPTION
99.1
99.2
104 Cover Page Interactive Data File (embedded within Inline XBRL document).

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
    BRADY CORPORATION
Date: May 16, 2025
  
  /s/ ANN E. THORNTON
  Ann E. Thornton
  Chief Financial Officer, Chief Accounting Officer and Treasurer


EX-99.1 2 exhibit991pressrelease0430.htm THIRD QUARTER FISCAL 2025 PRESS RELEASE Document

EXHIBIT 99.1


For More Information:
Investor contact: Ann Thornton 414-438-6887
Media contact: Kate Venne 414-358-5176


Brady Corporation Reports Record Adjusted EPS in its Fiscal 2025 Third Quarter and Tightens its Fiscal 2025 EPS Guidance

•Sales for the quarter increased 11.4 percent. Organic sales increased 1.6 percent, acquisitions increased sales 10.5 percent and foreign currency translation decreased sales 0.7 percent.
•Diluted EPS increased 3.8 percent to $1.09 in the third quarter of fiscal 2025 compared to $1.05 in the same quarter of the prior year. Adjusted Diluted EPS* increased 11.9 percent to a record high of $1.22 in the third quarter of fiscal 2025 compared to $1.09 in the same quarter of the prior year.
•Returned $44.5 million in the quarter to shareholders in the form of dividends and share repurchases.
•The Company’s Adjusted Diluted EPS* Guidance range for the full year ending July 31, 2025 was tightened from a range of $4.45 to $4.70 per share to $4.48 to $4.63 per share, and the previous range of GAAP earnings per diluted Class A Nonvoting Common share guidance was updated to $3.95 to $4.10 per share.

MILWAUKEE (May 16, 2025) -- Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results for its fiscal 2025 third quarter ended April 30, 2025.

Quarter Ended April 30, 2025 Financial Results:
Sales for the quarter ended April 30, 2025 increased 11.4 percent, which consisted of organic sales growth of 1.6 percent, growth of 10.5 percent from acquisitions and a decline of 0.7 percent from foreign currency translation. Sales for the quarter ended April 30, 2025 were $382.6 million compared to $343.4 million in the same quarter last year. By region, sales increased 12.9 percent in the Americas & Asia and sales increased 8.7 percent in Europe & Australia, which consisted of organic sales growth of 5.4 percent in the Americas & Asia and an organic sales decline of 5.4 percent in Europe & Australia.
Income before income taxes increased 2.1 percent to $65.7 million in the quarter ended April 30, 2025, compared to $64.4 million in the same quarter last year. Adjusted Income Before Income Taxes* in the quarter ended April 30, 2025, which was adjusted for amortization expense and facility closure and other reorganization costs of $8.7 million, was $74.4 million, an increase of 11.5 percent compared to the same quarter last year.
Net income for the quarter ended April 30, 2025 was $52.3 million compared to $50.9 million in the same quarter last year. Adjusted Net Income* in the quarter ended April 30, 2025 was $58.8 million compared to $52.7 million in the same quarter last year. Earnings per diluted Class A Nonvoting Common Share was $1.09 compared to $1.05 in the same quarter last year. Adjusted Diluted EPS* in the quarter ended April 30, 2025 was $1.22 compared to $1.09 in the same quarter last year.




Nine-Month Period Ended April 30, 2025 Financial Results:
Sales for the nine-month period ended April 30, 2025 increased 11.9 percent, which consisted of organic sales growth of 2.6 percent, growth of 10.2 percent from acquisitions, a decline of 0.5 percent from foreign currency translation and a decline of 0.4 percent from divestitures. Sales for the nine months ended April 30, 2025 were $1.12 billion compared to $998.0 million in the same period last year. By region, sales increased 11.4 percent in the Americas & Asia and sales increased 12.8 percent in Europe & Australia, which consisted of organic growth of 5.0 percent in the Americas & Asia and an organic sales decline of 1.9 percent in Europe & Australia.
Income before income taxes decreased 1.7 percent to $176.6 million in the nine-month period ended April 30, 2025, compared to $179.6 million in the same period last year. Adjusted Income Before Income Taxes* in the nine-month period ended April 30, 2025, which was adjusted for amortization expense, facility closure and other reorganization costs and acquisition-related charges of $28.8 million, was $205.4 million, an increase of 10.0 percent compared to the same period last year.
Net income in the nine-month period ended April 30, 2025 was $139.4 million compared to $141.8 million in the same period last year. Adjusted Net Income* in the nine-month period ended April 30, 2025 was $161.1 million compared to $147.2 million in the same period last year. Earnings per diluted Class A Nonvoting Common Share was $2.89 compared to $2.91 in the same period last year. Adjusted Diluted EPS* in the nine-month period ended April 30, 2025 was $3.34 compared to $3.03 in the same period last year.

Commentary:
“Our organic sales growth in the Americas & Asia region was strong this quarter, which was driven by our increased investments in research and development and new product launches over the last several years. The result was a new all-time company record quarter of adjusted earnings per share,” said Brady’s President and Chief Executive Officer, Russell R. Shaller. “While the tariff situation is currently uncertain, we will continue to focus on the execution of our strategic initiatives and we expect to utilize our global manufacturing presence to navigate trade developments throughout our businesses.”
“In addition to our record adjusted EPS this quarter, we also used our strong balance sheet and cash generation to return funds to our shareholders through share buybacks and increased dividends. This quarter, we repurchased 476,000 shares for $33.2 million, and we returned another $11.3 million to our shareholders in the form of dividends,” said Brady’s Chief Financial Officer, Ann Thornton. “Our balance sheet provides us with the ability to continue to invest in both organic growth and strategic acquisitions to increase shareholder value, along with stability during this period of uncertainty surrounding the global trade environment.”

Fiscal 2025 Guidance:
The Company tightened its Adjusted Diluted EPS* guidance for the year ending July 31, 2025 from $4.45 to $4.70 per share to $4.48 to $4.63 per share. The Company’s GAAP earnings per diluted Class A Nonvoting Share guidance for the year ending July 31, 2025 was updated for facility closure and other reorganization costs incurred to date to $3.95 to $4.10 per share, from $3.99 to $4.24 per share.
The assumptions included in fiscal 2025 guidance include a full-year income tax rate of approximately 20 percent, depreciation and amortization expense of approximately $40 million, and capital expenditures of approximately $25 million. Fiscal 2025 guidance is based upon foreign currency exchange rates as of April 30, 2025 and assumes economic growth.



A webcast regarding Brady’s fiscal 2025 third quarter financial results will be available at www.bradycorp.com/investors beginning at 9:30 a.m. central time today.

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2024, employed approximately 5,700 people in its worldwide businesses. Brady’s fiscal 2024 sales were approximately $1.34 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradyid.com.

* Adjusted Income Before Income Taxes, Adjusted Net Income, and Adjusted Diluted EPS are non-GAAP measures. See appendix for more information on these measures, including reconciliations to the most directly comparable GAAP measures.
###

In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of materials, labor, material shortages and supply chain disruptions, including as a result of tariffs or other impacts of the global trade environment; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady’s ability to identify, integrate and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting our websites, networks, and systems against security breaches; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; global climate change and environmental regulations; litigation, including product liability claims; foreign currency fluctuations; changes in tax legislation and tax rates; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2024.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.


BRADY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited; Dollars in thousands, except per share data)

Three months ended April 30, Nine months ended April 30,
  2025 2024 2025 2024
Net sales $ 382,590  $ 343,384  $ 1,116,330  $ 997,991 
Cost of goods sold 187,531  166,357  555,739  487,162 
Gross margin 195,059  177,027  560,591  510,829 
Operating expenses:
Research and development 19,191  17,681  56,835  50,215 
Selling, general and administrative 108,678  95,803  326,410  283,415 
Total operating expenses 127,869  113,484  383,245  333,630 
Operating income 67,190  63,543  177,346  177,199 
Other (expense) income:
Investment and other (expense) income (509) 1,596  2,850  4,718 
Interest expense (936) (728) (3,604) (2,284)
Income before income taxes 65,745  64,411  176,592  179,633 
Income tax expense 13,482  13,521  37,212  37,874 
Net income $ 52,263  $ 50,890  $ 139,380  $ 141,759 
Net income per Class A Nonvoting Common Share:
Basic $ 1.10  $ 1.06  $ 2.92  $ 2.94 
Diluted $ 1.09  $ 1.05  $ 2.89  $ 2.91 
Net income per Class B Voting Common Share:
Basic $ 1.10  $ 1.06  $ 2.90  $ 2.92 
Diluted $ 1.09  $ 1.05  $ 2.88  $ 2.90 
Weighted average common shares outstanding:
Basic 47,644  48,004  47,743  48,294 
Diluted 48,066  48,386  48,196  48,640 



BRADY CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)

  April 30, 2025 July 31, 2024
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 152,154  $ 250,118 
Accounts receivable, net of allowance for credit losses of $8,967 and $6,749, respectively 224,358  185,486 
Inventories 189,991  152,729 
Prepaid expenses and other current assets 15,399  11,382 
Total current assets 581,902  599,715 
Property, plant and equipment—net 219,082  195,758 
Goodwill 682,554  589,611 
Other intangible assets 111,685  51,839 
Deferred income taxes 20,583  15,596 
Operating lease assets 58,118  38,504 
Other assets 24,191  24,546 
Total $ 1,698,115  $ 1,515,569 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 99,754  $ 84,691 
Accrued compensation and benefits 87,506  77,954 
Taxes, other than income taxes 19,711  14,061 
Accrued income taxes 2,976  7,424 
Current operating lease liabilities 15,030  13,382 
Other current liabilities 86,809  67,170 
Total current liabilities 311,786  264,682 
Long-term debt 102,819  90,935 
Long-term operating lease liabilities 43,772  25,342 
Other liabilities 72,185  67,952 
Total liabilities 530,562  448,911 
Stockholders’ equity:
Common stock:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 43,774,580 and 44,042,462 shares, respectively 513  513 
Class B voting common stock—Issued and outstanding, 3,538,628 shares 35  35 
Additional paid-in capital 357,545  353,654 
Retained earnings 1,279,168  1,174,025 
Treasury stock—7,486,907 and 7,219,025 shares, respectively, of Class A nonvoting common stock, at cost (375,974) (351,947)
Accumulated other comprehensive loss (93,734) (109,622)
Total stockholders’ equity 1,167,553  1,066,658 
Total $ 1,698,115  $ 1,515,569 



BRADY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited; Dollars in thousands)

Nine months ended April 30,
2025 2024
Operating activities:
Net income $ 139,380  $ 141,759 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 30,279  22,406 
Stock-based compensation expense 9,762  6,422 
Deferred income taxes (6,038) (6,902)
Other (181) 1,358 
Changes in operating assets and liabilities:
Accounts receivable (6,869) (15,915)
Inventories (8,209) 20,861 
Prepaid expenses and other assets (3,754) (1,849)
Accounts payable and accrued liabilities (26,415) 7,347 
Income taxes (5,081) (4,393)
Net cash provided by operating activities 122,874  171,094 
Investing activities:
Purchases of property, plant and equipment (18,685) (69,157)
Acquisition of businesses, net of cash acquired (147,248) — 
Other 854  (1,174)
Net cash used in investing activities (165,079) (70,331)
Financing activities:
Payment of dividends (34,237) (33,890)
Proceeds from exercise of stock options 5,759  5,583 
Payments for employee taxes withheld from stock-based awards (2,518) (2,664)
Purchase of treasury stock (33,155) (72,225)
Proceeds from borrowing on credit agreement 206,249  111,790 
Repayment of borrowing on credit agreement (194,365) (97,732)
Other 190  149 
Net cash used in financing activities (52,077) (88,989)
Effect of exchange rate changes on cash and cash equivalents (3,682) (2,848)
Net (decrease) increase in cash and cash equivalents (97,964) 8,926 
Cash and cash equivalents, beginning of period 250,118  151,532 
Cash and cash equivalents, end of period $ 152,154  $ 160,458 



BRADY CORPORATION AND SUBSIDIARIES
SEGMENT INFORMATION
(Unaudited; Dollars in thousands)

Three months ended April 30, Nine months ended April 30,
2025 2024 2025 2024
NET SALES
Americas & Asia $ 253,652  $ 224,766  $ 732,926  $ 658,035 
Europe & Australia 128,938  118,618  383,404  339,956 
Total $ 382,590  $ 343,384  $ 1,116,330  $ 997,991 
SALES INFORMATION
Americas & Asia
Organic 5.4  % 4.5  % 5.0  % 3.0  %
Acquisitions 8.6  % —  % 7.9  % —  %
Currency (1.1) % (0.1) % (1.0) % —  %
Divestiture —  % (3.5) % (0.5) % (3.5) %
Total 12.9  % 0.9  % 11.4  % (0.5) %
Europe & Australia
Organic (5.4) % 4.4  % (1.9) % 2.8  %
Acquisitions 14.2  % —  % 14.8  % —  %
Currency (0.1) % (0.6) % (0.1) % 1.9  %
Total 8.7  % 3.8  % 12.8  % 4.7  %
Total Company
Organic 1.6  % 4.5  % 2.6  % 3.0  %
Acquisitions 10.5  % —  % 10.2  % —  %
Currency (0.7) % (0.3) % (0.5) % 0.6  %
Divestiture —  % (2.3) % (0.4) % (2.4) %
Total 11.4  % 1.9  % 11.9  % 1.2  %
SEGMENT PROFIT
Americas & Asia $ 57,164  $ 49,697  $ 158,148  $ 143,489 
Europe & Australia 17,478  19,537  41,872  51,335 
Total segment profit $ 74,642  $ 69,234  $ 200,020  $ 194,824 
SEGMENT PROFIT AS A PERCENT OF NET SALES
Americas & Asia 22.5  % 22.1  % 21.6  % 21.8  %
Europe & Australia 13.6  % 16.5  % 10.9  % 15.1  %
Total 19.5  % 20.2  % 17.9  % 19.5  %
Three months ended April 30, Nine months ended April 30,
2025 2024 2025 2024
Total segment profit $ 74,642  $ 69,234  $ 200,020  $ 194,824 
Unallocated amounts:
Administrative costs (7,452) (5,691) (22,674) (17,625)
Investment and other (expense) income (509) 1,596  2,850  4,718 
Interest expense (936) (728) (3,604) (2,284)
Income before income taxes $ 65,745  $ 64,411  $ 176,592  $ 179,633 



GAAP to NON-GAAP MEASURES
(Unaudited; Dollars in Thousands, Except Per Share Amounts)
In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.
Adjusted Income Before Income Taxes:
Brady is presenting the non-GAAP measure, "Adjusted Income Before Income Taxes." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Adjusted Income Before Income Taxes:
Three months ended April 30, Nine months ended April 30,
2025 2024 2025 2024
Income before income taxes (GAAP measure) $ 65,745  $ 64,411  $ 176,592  $ 179,633 
Amortization expense 4,754  2,365  14,138  7,084 
Facility closure and other reorganization costs 3,930  —  9,584  — 
Non-recurring acquisition-related costs and other expenses —  —  5,059  — 
Adjusted Income Before Income Taxes (non-GAAP measure) $ 74,429  $ 66,776  $ 205,373  $ 186,717 


Adjusted Income Tax Expense:
Brady is presenting the non-GAAP measure, "Adjusted Income Tax Expense." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Adjusted Income Tax Expense:
Three months ended April 30, Nine months ended April 30,
2025 2024 2025 2024
Income tax expense (GAAP measure) $ 13,482  $ 13,521  $ 37,212  $ 37,874 
Amortization expense 1,144  548  3,402  1,642 
Facility closure and other reorganization costs 983  —  2,396  — 
Non-recurring acquisition-related costs and other expenses —  —  1,265  — 
Adjusted Income Tax Expense (non-GAAP measure) $ 15,609  $ 14,069  $ 44,275  $ 39,516 




Adjusted Net Income:
Brady is presenting the non-GAAP measure, "Adjusted Net Income." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Adjusted Net Income:
Three months ended April 30, Nine months ended April 30,
2025 2024 2025 2024
Net income (GAAP measure) $ 52,263  $ 50,890  $ 139,380  $ 141,759 
Amortization expense 3,610  1,817  10,736  5,442 
Facility closure and other reorganization costs 2,947  —  7,188  — 
Non-recurring acquisition-related costs and other expenses —  —  3,794  — 
Adjusted Net Income (non-GAAP measure) $ 58,820  $ 52,707  $ 161,098  $ 147,201 


Adjusted Diluted EPS:
Brady is presenting the non-GAAP measure, "Adjusted Diluted EPS." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Adjusted Diluted EPS (Note that certain amounts will not foot due to rounding):
Three months ended April 30, Nine months ended April 30,
2025 2024 2025 2024
Net income per Class A Nonvoting Common Share (GAAP measure) $ 1.09  $ 1.05  $ 2.89  $ 2.91 
Amortization expense 0.08  0.04  0.22  0.11 
Facility closure and other reorganization costs 0.06  —  0.15  — 
Non-recurring acquisition-related costs and other expenses —  —  0.08  — 
Adjusted Diluted EPS (non-GAAP measure) $ 1.22  $ 1.09  $ 3.34  $ 3.03 


Adjusted Diluted EPS Guidance:
Fiscal 2025 Expectations
Low High
Earnings per Class A Nonvoting Common Share (GAAP measure) $ 3.95  $ 4.10 
Amortization expense 0.30  0.30 
Facility closure and other reorganization costs 0.15  0.15 
Non-recurring acquisition-related costs and other expenses 0.08  0.08 
Adjusted Diluted EPS (non-GAAP measure) $ 4.48  $ 4.63 

EX-99.2 3 f25q3conferencecallprese.htm THIRD QUARTER FISCAL 2025 INFORMATIONAL SLIDES f25q3conferencecallprese
F’25 Q3 Financial Results Brady Corporation May 16, 2025

 
Forward-Looking Statements In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations. The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of materials, labor, material shortages and supply chain disruptions, including as a result of tariffs or other impacts of the global trade environment; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady’s ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting our websites, networks and systems against security breaches; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; global climate change and environmental regulations; litigation, including product liability claims; foreign currency fluctuations; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; changes in tax legislation and tax rates; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2024. These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward- looking statements. Brady does not undertake to update its forward-looking statements except as required by law. 2

 
Q3 F’25 Highlights 3 * Adjusted Diluted Earnings per Share is a non-GAAP measure. See appendix. Organic sales growth of 1.6%. Americas & Asia organic sales growth of 5.4%. Europe & Australia organic sales decline of 5.4%. Acquisition growth of 10.5%. Sales Growth GPM of 51.0% compared to 51.6% in Q3 of F’24. Gross profit includes facility closure and other reorganization costs in Q3 F’25. Gross Profit Margin GAAP EPS increased 3.8% to $1.09 in Q3 of F’25 compared to $1.05 in Q3 of F’24. Adjusted Diluted Earnings per Share* increased 11.9% to $1.22 in Q3 of F’25 compared to $1.09 in Q3 of F’24. Growth in Earnings per Share Purchased 476k shares in Q3 of F’25 for $33.2M (average price = $69.64 per share). Paid dividends of $11.3M in the quarter. In a net cash position of $49.3M at April 30, 2025. Returned Funds to our Shareholders F’25 EPS Guidance Tightening full year F’25 Adjusted EPS guidance to $4.48 to $4.63 per share from $4.45 to $4.70 per share. Tightening full year F’25 GAAP EPS guidance to $3.95 to $4.10 per share from $3.99 to $4.24 per share.

 
AustraliaEurope, Middle East & AfricaChina Geographic Presence 4 Asia (excl. China) 52% 6% 5% 3% 30% 4% Rest of AmericasU.S.A. YTD Q3 F’25 Sales by Geography (90 facilities in 35 countries) Austria, Belgium, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Qatar, Saudi Arabia, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey, UAE, U.K. Brazil, Canada, Mexico. India, Japan, Malaysia, Philippines, South Korea, Singapore, Thailand, Vietnam.

 
Sales Overview 5 Q3 F’25 SALES: Total sales increased 11.4%. Organic sales increased 1.6%. • Americas & Asia – Organic sales increased 5.4%. • Europe & Australia – Organic sales declined 5.4%. Foreign currency translation decreased sales 0.7%. Acquisitions increased sales 10.5%. $321 $318 $339 $324 $323 $326 $337 $346 $332 $323 $343 $343 $377 $357 $383 $225 $250 $275 $300 $325 $350 $375 $400 Q1 F'22 7.0% Q2 F'22 13.1% Q3 F'22 9.0% Q4 F'22 9.0% Q1 F'23 6.9% Q2 F'23 6.3% Q3 F'23 1.9% Q4 F'23 6.9% Q1 F'24 2.7% Q2 F'24 1.6% Q3 F'24 4.5% Q4 F'24 1.6% Q1 F'25 3.6% Q2 F'25 2.6% Q3 F'25 1.6%Organic Growth SALES (millions of USD) Q3 F’25 SALES COMMENTARY: Organic sales grew 3.3% in the Americas with growth in most major product lines. Asia organic sales grew 22.9% with growth across the region, including China. Organic sales declined 5.1% in Europe and declined 8.1% in Australia.

 
Gross Profit Margin 6 $155 $149 $164 $163 $155 $156 $170 $176 $172 $162 $177 $177 $190 $176 $19548.2% 47.0% 48.4% 50.4% 48.1% 48.0% 50.3% 50.8% 51.7% 50.2% 51.6% 51.6% 50.3% 49.3% 51.0% 38% 40% 42% 44% 46% 48% 50% 52% $100 $125 $150 $175 $200 $225 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 GROSS PROFIT & GPM% (millions of USD) Q3 F’25 – GROSS PROFIT MARGIN: Gross profit margin of 51.0% compared to 51.6% in Q3 of F’24. The impact of facility closures and other reorganization costs reduced gross profit margin by approximately 30 basis points in Q3 of F’25.

 
SG&A Expense 7 Q3 F’25 – SG&A EXPENSE: SG&A expense increased as a percent of sales when compared to Q3 last year primarily due to increased amortization and facility closure and other reorganization costs. Amortization expense was $4.8M in Q3 of F’25 and $2.4M in Q3 of F’24, and facility closure and other reorganization costs were $3.9M in Q3 of F’25. We continue to drive efficiencies in SG&A expenses while investing in sales-generating resources. $97 $93 $96 $95 $90 $92 $91 $97 $96 $91 $96 $93 $112 $106 $109 30.1% 29.1% 28.4% 29.2% 27.9% 28.3% 27.0% 28.2% 29.0% 28.3% 27.9% 27.2% 29.7% 29.7% 28.4% 10% 15% 20% 25% 30% 35% $60 $70 $80 $90 $100 $110 $120 $130 $140 $150 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 SG&A EXPENSE AND SG&A EXPENSE AS A % OF SALES (millions of USD)

 
R&D Expense 8 Q3 F’25 – R&D EXPENSE: We remain committed to our investments in R&D in order to drive profitable long-term sales growth through our new product roadmap. $13.9 $14.0 $14.9 $15.8 $13.9 $15.4 $15.7 $16.3 $15.7 $16.8 $17.7 $17.5 $18.9 $18.7 $19.2 4.3% 4.4% 4.4% 4.9% 4.3% 4.7% 4.7% 4.7% 4.7% 5.2% 5.1% 5.1% 5.0% 5.2% 5.0% 1.5% 2.5% 3.5% 4.5% 5.5% $10.0 $12.0 $14.0 $16.0 $18.0 $20.0 $22.0 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 R&D EXPENSE AND R&D EXPENSE AS A % OF SALES (millions of USD)

 
Income Before Income Taxes 9 $44.7 $42.0 $51.3 $54.0 $50.3 $48.5 $63.0 $63.8 $59.4 $55.8 $64.4 $68.2 $58.8 $52.0 $65.7 $10 $20 $30 $40 $50 $60 $70 Q1 F'22 5.8% Q2 F'22 6.7% Q3 F'22 7.3% Q4 F'22 29.7% Q1 F'23 12.6% Q2 F'23 15.4% Q3 F'23 23.0% Q4 F'23 18.2% Q1 F'24 18.0% Q2 F'24 15.1% Q3 F'24 2.2% Q4 F'24 6.9% Q1 F'25 (1.0%) Q2 F'25 (6.8%) Q3 F'25 2.1% * Adjusted Income Before Income Taxes is a non-GAAP measure. See appendix. (millions of USD)INCOME BEFORE INCOME TAXES (GAAP) Q3 F’25 – INCOME BEFORE INCOME TAXES: GAAP Income before income taxes increased 2.1% to $65.7M in Q3 of F’25 compared to $64.4M in Q3 of F’24. Excluding adjusted* items from both periods, income before income taxes increased 11.5% to $74.4M in Q3 of F’25 compared to $66.8M in Q3 of F’24. Year-on-Year Growth (Decline)

 
Net Income & Diluted EPS 10 Q3 F’25 – NET INCOME & DILUTED EPS: GAAP Net Income was $52.3M in Q3 of F’25 compared to $50.9M in Q3 of F’24 (increased 2.7%). • Adjusted Net Income* was $58.8M in Q3 of F’25 compared to $52.7M in Q3 of F’24 (increased 11.6%). GAAP Diluted EPS was $1.09 in Q3 of F’25 compared to $1.05 in Q3 of F’24. • Adjusted Diluted EPS* was $1.22 in Q3 of F’25 compared to $1.09 in Q3 of F’24 (increased 11.9%). * Adjusted Net Income and Adjusted Diluted EPS are non-GAAP measures. See appendix. $35.0 $33.8 $40.1 $41.1 $39.4 $38.0 $48.1 $49.4 $47.2 $43.6 $50.9 $55.5 $46.8 $40.3 $52.3 $20 $30 $40 $50 $60 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 NET INCOME (GAAP) (millions of USD) $0.67 $0.65 $0.78 $0.81 $0.79 $0.76 $0.96 $1.00 $0.97 $0.90 $1.05 $1.15 $0.97 $0.83 $1.09 $0.40 $0.60 $0.80 $1.00 $1.20 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 DILUTED EPS (GAAP)

 
Cash Generation 11 CASH FLOW FROM OPERATING ACTIVITIES $27.5 ($3.2) $40.9 $53.2 $28.0 $29.4 $72.5 $79.3 $62.3 $36.1 $72.7 $84.0 $23.4 $39.6 $59.9 -$5 $20 $45 $70 $95 Q1 F'22 78% Q2 F'22 (9%) Q3 F'22 102% Q4 F'22 130% Q1 F'23 71% Q2 F'23 77% Q3 F'23 151% Q4 F'23 161% Q1 F'24 132% Q2 F'24 83% Q3 F'24 143% Q4 F'24 151% Q1 F'25 50% Q2 F'25 98% Q3 F'25 115%% of Net Income CASH FLOWS IN Q3 OF F’25: Overview: Cash flow from operating activities was $59.9M in Q3 of F’25 vs. $72.7M in Q3 of F’24. Free cash flow* was $55.6M in Q3 of F’25 compared to $64.4M in Q3 of F’24. Returning Funds to our Shareholders: In F’25, we returned a total of $67.4M to our shareholders in the form of dividends and share buybacks. Dividends – Increased our annual dividend for the 39th consecutive year. Share Buybacks – Repurchased 476k shares in Q3 F’25 for $33.2M (average price of $69.64/share). * Free cash flow is calculated as Net Cash Provided by Operating Activities less Capital Expenditures. (millions of USD) (millions of USD) 3 Mos. Ended Apr. 30, 2025 3 Mos. Ended Apr. 30, 2024 9 Mos. Ended Apr. 30, 2025 9 Mos. Ended Apr. 30, 2024 Cash Balance - Beginning of Period 138.5$ 143.9$ 250.1$ 151.5$ Cash Flow from Operating Activities 59.9 72.7 122.9 171.1 Capital Expenditures (4.3) (8.3) (18.7) (69.2) Dividends (11.3) (11.2) (34.2) (33.9) Share Repurchases (33.2) (50.4) (33.2) (72.2) Business Acquisitions (9.9) - (147.2) - Net Debt Borrowings 15.1 15.7 11.9 14.1 Effect of Exchange Rates on Cash (3.1) (0.6) (3.7) (2.8) Other 0.5 (1.3) 4.3 1.9 Cash Balance - End of Period 152.2$ 160.5$ 152.2$ 160.5$

 
Net Cash 12 STRONG BALANCE SHEET: April 30, 2025 cash = $152.2M. April 30, 2025 debt = $102.8M. Balance sheet provides flexibility for future organic investments and strategic M&A. $91 $64 $26 $19 $15 $31 $84 $102 $123 $96 $97 $159 $29 $51 $49 $0 $50 $100 $150 $200 $250 $300 $350 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 NET CASH (millions of USD)

 
F’25 Updated Diluted EPS Guidance GAAP Diluted EPS $3.95 to $4.10 F’25 Adjusted Diluted EPS* $4.48 to $4.63 Guidance Assumptions: Organic sales growth in the low-single digit percentages. Full-year income tax rate of approximately 20%. Foreign currency exchange rates as of April 30, 2025. Depreciation and amortization expense of approximately $40M. Capital expenditures of approximately $25M. 13 * Adjusted Diluted EPS is a non-GAAP measure. See appendix.

 
Americas & Asia 14 • Revenues increased 12.9% in Q3 of F’25: • Organic growth = + 5.4%. • Fx decrease = (1.1%). • Acquisition = + 8.6%. • Organic sales grew 3.3% in the Americas with growth in most major product lines. • Organic sales grew 22.9% in Asia; growth throughout the region including China. • Growth in segment profit due to organic sales growth in higher gross margin product lines, which was partially offset by increased amortization from acquisitions and facility closure and other reorganization costs. Excluding these increased costs, segment profit increased 20.2%. Q3 F’25 SUMMARY:Q3 F’25 vs. Q3 F’24 (millions of USD) $218 $220 $223 $227 $222 $212 $225 $228 $245 $234 $254 19% 18% 22% 22% 23% 21% 22% 23% 22% 20% 23% 0% 5% 10% 15% 20% 25% $50 $100 $150 $200 $250 $300 Q1 F'23 4.0% (1.4%) - Q2 F'23 6.9% (1.0%) - Q3 F'23 1.2% (0.8%) (0.3%) Q4 F'23 5.6% (0.2%) (1.0%) Q1 F'24 3.3% - (1.9%) Q2 F'24 1.2% 0.1% (5.1%) Q3 F'24 4.5% (0.1%) (3.5%) Q4 F'24 3.4% (0.8%) (2.2%) Q1 F'25 5.1% (0.2%) 5.8% Q2 F'25 4.3% (1.4%) 7.6% Q3 F'25 5.4% (1.1%) 8.6% SALES & SEGMENT PROFIT % (millions of USD) Q3 F’25 Q3 F’24 Change Sales $ 253.7 $ 224.8 12.9% Segment Profit 57.2 49.7 + 15.0% Segment Profit % 22.5% 22.1% + 40 bps • Low-single digit organic sales growth in Q4 F’25. • Growth in segment profit excluding amortization and facility closure and other reorganization costs. OUTLOOK: Organic For. Curr. Acq. & Div.

 
Europe & Australia 15 • Revenues increased 8.7% in Q3 of F’25: • Organic decline = (5.4%). • Fx decrease = (0.1%). • Acquisition = 14.2% • Organic sales declined 5.1% in Europe and declined 8.1% in Australia. • Segment profit decreased due to the decline in organic sales, as well as increased amortization and facility closure and other reorganization costs. Excluding these increased costs, segment profit increased 3.8%. Q3 F’25 SUMMARY:Q3 F’25 vs. Q3 F’24 (millions of USD) $104 $106 $114 $118 $110 $111 $119 $115 $132 $123 $129 16% 13% 15% 16% 15% 14% 16% 17% 10% 9% 14% 0% 5% 10% 15% 20% $50 $100 $150 $200 $250 $300 Q1 F'23 12.8% (17.0%) - Q2 F'23 5.2% (8.9%) - Q3 F'23 3.4% (4.8%) - Q4 F'23 9.5% 2.0% - Q1 F'24 1.4% 4.6% - Q2 F'24 2.5% 2.0% - Q3 F'24 4.4% (0.6%) - Q4 F'24 (1.8%) (1.2%) - Q1 F'25 0.7% 3.6% 15.0% Q2 F'25 (0.8%) (3.6%) 15.1% Q3 F'25 (5.4%) (0.1%) 14.2% SALES & SEGMENT PROFIT % Q3 F’25 Q3 F’24 Change Sales $ 128.9 $ 118.6 8.7% Segment Profit 17.5 19.5 (10.5%) Segment Profit % 13.6% 16.5% - 290 bps Organic For. Curr. Acquisitions • Organic sales approximately flat in Q4 F’25 due to challenging macro environment. • Growth in segment profit excluding amortization and facility closure and other reorganization costs. OUTLOOK: (millions of USD)

 
Investor Relations Brady Contact: Ann Thornton Investor Relations 414-438-6887 Ann_Thornton@bradycorp.com See our website at www.bradycorp.com/investors 16

 
Appendix GAAP to Non-GAAP Reconciliations

 
Non-GAAP Reconciliations 18 2025 2024 2025 2024 65,745$ 64,411$ 176,592$ 179,633$ Amortization expense 4,754 2,365 14,138 7,084 Facility closure and other reorganization costs 3,930 - 9,584 - Non-recurring acquisition-related costs and other expenses - - 5,059 - 74,429$ 66,776$ 205,373$ 186,717$ 2025 2024 2025 2024 13,482$ 13,521$ 37,212$ 37,874$ Amortization expense 1,144 548 3,402 1,642 Facility closure and other reorganization costs 983 - 2,396 - Non-recurring acquisition-related costs and other expenses - - 1,265 - 15,609$ 14,069$ 44,275$ 39,516$ GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Three months ended April 30, Three months ended April 30, Adjusted Income Tax Expense (non-GAAP measure) Income before income taxes Adjusted Income Before Income Taxes (non-GAAP measure) Brady is presenting the non-GAAP measure, "Adjusted Income Tax Expense." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Adjusted Income Tax Expense: Nine months ended April 30, Adjusted Income Before Income Taxes: Brady is presenting the non-GAAP measure, "Adjusted Income Before Income Taxes." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Adjusted Income Before Income Taxes: Adjusted Income Tax Expense: Nine months ended April 30, Income tax expense (GAAP measure)

 
Non-GAAP Reconciliations 19 2025 2024 2025 2024 52,263$ 50,890$ 139,380$ 141,759$ Amortization expense 3,610 1,817 10,736 5,442 Facility closure and other reorganization costs 2,947 - 7,188 - Non-recurring acquisition-related costs and other expenses - - 3,794 - 58,820$ 52,707$ 161,098$ 147,201$ 2025 2024 2025 2024 $ 1.09 $ 1.05 $ 2.89 $ 2.91 Amortization expense 0.08 0.04 0.22 0.11 Facility closure and other reorganization costs 0.06 - 0.15 - Non-recurring acquisition-related costs and other expenses - - 0.08 - 1.22$ 1.09$ 3.34$ 3.03$ Diluted EPS Excluding Certain Items Guidance: Low High Earnings per diluted Class A Common Share (GAAP measure) $ 3.95 $ 4.10 Amortization expense 0.30 0.30 Facility closure and other reorganization costs 0.15 0.15 Non-recurring acquisition-related costs and other expenses 0.08 0.08 Adjusted Diluted EPS (non-GAAP measure) 4.48$ 4.63$ Adjusted Net Income: Fiscal 2025 Expectations Three months ended April 30, Brady is presenting the non-GAAP measure, "Adjusted Diluted EPS." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Adjusted Diluted EPS (Note that certain amounts will not foot due to rounding): Nine months ended April 30, Net income per Class A Nonvoting Common Share (GAAP measure) Adjusted Diluted EPS: GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Adjusted Diluted EPS (non-GAAP measure) Three months ended April 30, Brady is presenting the non-GAAP measure, "Adjusted Net Income." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Adjusted Net Income: Nine months ended April 30, Net income (GAAP measure) Adjusted Net Income (non-GAAP measure)